« Back
Home /
Rhosin (hydrochloride)

Rhosin (hydrochloride)

Item no.	HY-12646-25mg
Manufacturer	MedChem Express
CASRN	1281870-42-5
Amount	25 mg
Quantity options	10 mM/1 mL 10 mg 1 mg 25 mg 50 mg 5 mg
Category	Cell Biology Cytoskeleton Inhibitors & Compound Libraries Small Molecules small GTPases Rho Subfamily
Type	Inhibitors
Specific against	other
Purity	99.93
Citations	[1]Shang X, et al. Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases. Chem Biol. 2012 Jun 22;19(6):699-710.\|[2]Shang X, et al. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3155-60.\|[3]Francis TC, et al. The Selective RhoA Inhibitor Rhosin Promotes Stress Resiliency Through Enhancing D1-Medium Spiny Neuron Plasticity and Reducing Hyperexcitability. Biol Psychiatry. 2019;85(12):1001-1010. Acta Pharmacol Sin. 2024 Mar 15.\|Biochem Pharmacol. 2023 Sep 23;115816.\|bioRxiv. 2023 Oct 16.\|bioRxiv. 2025 Mar 4:2025.02.27.640687.\|Cancer Biol Ther. 2018;19(12):1193-1203. \|Cell Death Dis. 2025 Jan 20;16(1):31.\|Circulation. 2021 May 4;143(18):1775-1792.\|Ecotoxicol Environ Saf. 2022 May 1;236:113454.\|Ecotoxicol Environ Saf. 2023 Apr 24;257:114940.\|Endocrinology. 2021 Apr 14;bqab077.\|FASEB J. 2020 Jan;34(1):1481-1496.\|J Mol Med (Berl). 2023 Oct 7.\|J Virol. 2024 Dec 31:e0140824.\|Kardiol Pol. 2021 Jun 27.\|Life Sci Alliance. 2024 Oct 28;8(1):e202402585.\|Microcirculation. 2021 Jan 23;e12680.\|Nat Commun. 2023 Mar 14;14(1):1402.\|Oncol Rep. 2021 Jan;45(1):83-94.\|Theranostics. 2022 May 9;12(8):3847-3861.\|Toxicology. 2024 Nov 9:509:153994.\|Antioxidants (Basel). 2022, 11(7), 1264.\|Biochem Biophys Res Commun. 2019 Oct 29;519(1):134-140.\|Cancer Res. 2022 Feb 15;82(4):681-694.\|Cell Death Dis. 2023 Apr 20;14(4):280.\|Cell Mol Bioeng. 06 October 2022.\|Chem Biol Interact. 17 August 2021, 109625.\|Exp Cell Res. 2024 Mar 1;436(1):113956.\|J Breast Cancer. 2019 Apr 22;22(2):185-195. \|SSRN. 2024 Feb 13.
Smiles	O=C(N/N=C/C1=CC=C2N=CC=NC2=C1)[C@H](N)CC3=CNC4=C3C=CC=C4.[H]Cl
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Shipping Condition	Room temperature
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	Cancer-Kinase/protease
Manufacturer - Targets	Apoptosis; Ras
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture)
Molecular Weight	394.86
Product Description	Rhosin hydrochloride is a potent, specific RhoA subfamily Rho GTPases inhibitor. Rhosin hydrochloride specifically binds to RhoA to inhibit RhoA-GEF interaction with a Kd of ~ 0.4 uM, and does not interact with Cdc42 or Rac1, nor the GEF, LARG. Rhosin hydrochloride induces cell apoptosis[1][2]. Rhosin hydrochloride promotes stress resiliency through enhancing D1-MSN plasticity and reducing hyperexcitability[3].
Manufacturer - Research Area	Cancer
Solubility	DMSO: 50 mg/mL (ultrasonic)\|H2O: 16.67 mg/mL (ultrasonic)
Manufacturer - Pathway	Apoptosis; GPCR/G Protein; MAPK/ERK Pathway
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12646-25mg-safety-datasheet.pdf